Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05227755 · ClinicalTrials.gov registry record · NA
High-protein Oral Supplement Improves Normalized Protein Catabolic Rate and Inflammation Markers
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05227755 is a NA study that has completed, run by University of Florida. The registered enrollment target is 15 participants.
The verdict
NCT05227755, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The investigators propose to determine the impact of high-protein beverages on protein status and inflammation markers among CKD patients undergoing hemodialysis. A 12-week double-blind randomized cross-over trial will be used in which participants (n=22) will consume a 4-ounce high protein supplement with either whey (20 g total protein) or soy (20 g total protein). Outcomes of interest include serum urea nitrogen and inflammation markers (CRP and IL-6). The findings will contribute to the knowledge gap regarding the effect of different protein types in CKD populations which can be translated to the development of affordable supplements to prevent malnutrition in adults with non-communicable diseases.
Interventions
- DIETARY_SUPPLEMENT Whey protein isolate
- DIETARY_SUPPLEMENT Soy protein isolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-08-05 |
| Est. Completion | 2023-11-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05227755
The ClinicalTrials.gov registry entry for NCT05227755 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Whey protein isolate is the first listed.
NCT05227755 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05227755 about?
NCT05227755 is a clinical study titled "High-protein Oral Supplement Improves Normalized Protein Catabolic Rate and Inflammation Markers". The investigators propose to determine the impact of high-protein beverages on protein status and inflammation markers among CKD patients undergoing hemodialysis. A 12-week double-blind randomized cross-over trial will be used in which participants (n=22) will consume a 4-ounce high protein suppleme...
What is the current status of trial NCT05227755?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-08-05. Estimated completion is 2023-11-21.
What interventions are being tested in trial NCT05227755?
The interventions under investigation include: Whey protein isolate (DIETARY_SUPPLEMENT), Soy protein isolate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05227755?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.